OBGYN.net: The Universe of Women's Health

OBGYN.net Editorial Advisor
Fibroid Resource Center & Discussion Forum

Robert L. Worthington-Kirsch, M.D., FSIR, FASA, RVT, RPVI - USA

Web site: www.fibroidcorner.com

Office Information

Image Guided Surgery Associates
Peripheral Vascular Institute of Philadelphia
4220 Market St, 2nd Floor
Philadelphia, PA  19104
Telephone: 215-240-6007

Experience and Interest

Robert L Worthington-Kirsch, MD was raised in Boston, Massachusetts, USA. He attended MIT, from which he received Bachelors Degrees in Molecular Biology and Comparative Western Religion (minor in Ancient and Medieval European History). He then attended Medical School at the University of Massachusetts, receiving his MD in 1986. During his Residency in Diagnostic Radiology at Mercy Catholic Medical Center in the Philadelphia area Dr Worthington-Kirsch discovered his passion for Interventional Radiology. He is Board Certified in Diagnostic Radiology and Subspecialty Certified in Vascular and Interventional Radiology.

Dr Worthington-Kirsch has been in practice in the Philadelphia area since 1990, concentrating on IR. He went into solo private practice of Interventional Radiology in 2002, with his practice titled Image Guided Surgery Associates. His main areas of practice are in fibroid embolization, treatment of superficial venous insufficiency, permanent birth control for women, and other IR procedures. Dr Worthington-Kirsch has been actively involved in research surrounding fibroid embolotherapy since 1996, and has the largest single operator experience with the procedure in the world.

Dr Worthington-Kirsch has also been active in his professional society. He served on the UAE Task Force of the Society of Interventional Radiology since its inception, and continues to serve on SIR’s UAE Advisory Council. He was one of the designers of the FIBROID Registry, and continues to serve on its Steering Committee. He also serves on the Venous Forum of the SIR. He is a Fellow of the Society of Interventional Radiology, of the American Society of Angiology, and a candidate for Fellowship in the CIRSE. He has given numerous invited presentations and scientific papers at the meetings of the SIR, CIRSE, and other Societies.

Dr Worthington-Kirsch and his wife of 24 years have 5 children, the oldest of whom is recently engaged to be married, and several pets. He serves as the Mohel for his local congregation, and is Chairman of the International Messianic Brit Milah Board. He also is a dedicated fly-fisherman in both fresh- and salt-water.

Peer-Reviewed Publications

1. Rothstein, A.M., Benedetto, J.D., Worthington-Kirsch, R.L., and Gefter, M.L. "Unique Determinants Associated with Hybridoma Proteins Expressing a Cross-Reactive Idiotype: Frequency Among Individual Immune Sera", J Immunol 1980; 125(5):1987-1992

2. Worthington-Kirsch, R.L., Raptopoulos, V., and Cohen, I.T. "Sequential Bilateral Torsion of Normal Ovaries in a Child", J Ultrasound Med 1986; 5:663-664

3. Bartter, T., Irwin, R.S., Phillips, D.A., Benotti, J.R., and Worthington-Kirsch, R.L. "Pulmonary Artery Pseudoaneurysm: A Potential Complication of Pulmonary Artery Catheterization", Arch Int Med 1988; 148:471-473

4. Worthington-Kirsch, R.L., Hutchins, F.L.,, and Popky, G.L. “Uterine Artery Embolization for the Management of Symptomatic Fibroids: Current Experience with 125 Patients and Follow-Up of Up to One Year” (abstract) Radiology 1998; 206(2):575

5. Worthington-Kirsch, R.L., Hutchins, F.L., and Popky, G.L. “Uterine Artery Embolization for Management of Symptomatic Fibroids: Mid-Term Results with 175 Patients and Follow-up to 18 Months” (abstract) Am J Roentgenol 1998; 170(Supp:4):34-35

6. Worthington-Kirsch, R.L., Hutchins, F.L., and Popky, G.L. “Uterine Arterial Embolization for the Management of Leiomyomas: Quality of Life Assessment and Clinical Response”, Radiology 1998; 208:625-629

7. Berkowitz, R.P., Hutchins, F.L., and Worthington-Kirsch, R.L. “Vaginal Expulsion of Submucosal Fibroids Following Uterine Artery Embolization: A Report of Three Cases”, J Reprod Med 1999; 44:373-376

8. Worthington-Kirsch, RL. “Flow Redistribution During Uterine Artery Embolization for the Management of Symptomatic Fibroids” (Letter) J Vasc Interv Radiol 1999; 10(2):237-238

9. Worthington-Kirsch, R.L., Hutchins, F.L., and Berkowitz, R.P. “Regarding Sloughing of Fibroids After Uterine Artery Embolization” (letter) J Vasc Interv Radiol 1999; 10:1135

10. Hutchins, F.L and Worthington-Kirsch, R.L. "GnRH Analogs and Uterine Artery Embolization" (letter), J Am Assoc Gynecol Laparosc 1999; 6(3):367-368

11. Hutchins, F.L., Worthington-Kirsch, R.L., and Berkowitz, R.P. “Selective Uterine Artery Embolization as Primary Treatment for Symptomatic Leiomyomata Uteri: A Review of 305 Consecutive Cases”, J Am Assoc Gynecol Laparosc 1999; 6(3):279-284

12. Walker, WJ and Worthington-Kirsch, RL. “Fatal Septicemia After Uterine Fibroid Embolisation” (letter), The Lancet 1999; 354(9191):1730

13. Worthington-Kirsch, R.L., Smith, S.J., and Berkowitz, R.P. “Transient Buttock Pain After Uterine Artery Embolisation for the Management of Fibroids”, Min Invas Ther & Allied Technol 1999; 8:425-427

14. Delaney, M.L., Worthington-Kirsch, R.L., Hutchins, F.L., and Berkowitz, R.P. “Uterine Artery Embolisation for the Management of Myomata in Patients without Complaints of Menorrhagia”, Min Invas Ther & Allied Technol 1999; 8:455-458

15. Worthington-Kirsch RL, Walker WJ, Adler L, and Hutchins FL. “Anatomic Variation in the Uterine Arteries: A Cause of Failure of Uterine Artery Embolisation for the Management of Symptomatic Myomata”, Min Invas Ther & Allied Technol 1999; 8:397-402

16. Worthington-Kirsch RL, ,Hutchins FL, and Berkowitz, RP. "Uterine Interstitial Gas after Uterine Artery Embolization: A Benign Finding", J Interv Radiol 1999; 14:181-185

17. Worthington-Kirsch RL. “Regarding the Anatomy of the Uterine Artery” (letter), Am J Roentgenol 2000; 174(1):258

18. Worthington-Kirsch, R.L. and Hutchins, F.L. "Retained Myoma Fragment after LASH Procedure ‑ Case Report and Imaging Findings" (Letter), Clin Radiol 2001; 56:777-778

19. Worthington-Kirsch RL, Fueredi GA, Goodwin SC, Machan L, Niedzwiecki GA, Reidy JF, Spies JB, Walker WJ. “Polyvinyl Alcohol Particle Size for Uterine Artery Embolization” (letter). Radiology 2001; 218:605-606

20. Spies JB, Benenati JF, Worthington-Kirsch RL. “Initial Experience with Use of Tris-acryl Gelatin Microspheres for Uterine Artery Embolization for Leiomyomata.”, J Vasc Interv Radiol 2001; 12:1059-1063

21. Worthington-Kirsch RL, Koller NE. “Time Course of Pain After Uterine Artery Embolization for Fibroid Disease”, Medscape Women’s Health e-Journal 2002

22. Worthington-Kirsch RL, Siskin GP. “Uterine Artery Embolization for Symptomatic Myomata”; J Intensive Care Med 2004:19:13-21

23. Worthington-Kirsch RL. “Modified Monorail Technique for Insertion of Tunneled Hemodialysis Catheters” (Letter), J Vasc Interv Radiol 2004; 15:303-304

24. Spies JB, Cooper JM, Worthington-Kirsch RL, Lipman JC, Mills BB, Benenati JF. “Outcome of Uterine Embolization and Hysterectomy for Leiomyomas: Results of a Multicenter Study”; Am J Ob Gyn 2004; 191:22-31

25. Worthington-Kirsch RL. “Uterine Artery Embolization: State of the Art” Sem Interv Radiol 2004; 21:37-42

26. Goldberg J, Burd I, Price FV, Worthington-Kirsch RL. “Leiomyosarcoma in a Pre-Menopausal Patient Following Uterine Artery Embolization”, Am J Obstet Gynecol 2004; 191:1733-1735

27. Myers E, Goodwin SC, Landow W, Mauro M, Peterson E, Pron G, Spies JB, Worthington-Kirsch RL. “Prospective Data Collection of a New Procedure by a Specialty Society: The FIBROID Registry”, Obstet Gynecol 2005; 106:44-51

28. Worthington-Kirsch RL. Spies JB, Myers E, Mulgund J, Mauro MA, Pron G, Peterson E, Goodwin SC, “The Fibroid Registry for Outcomes Data (FIBROID) for Uterine Artery Embolization”, Obst et Gynecol 2005; 106:52-59

29. Spies JB, Myers ER, Worthington-Kirsch RL, Mulgund J, Mauro M, Pron G, Peterson E, Goodwin SC, The Fibroid Registry for Outcomes Data (FIBROID) for Uterine Artery Embolization: Outcome from Therapy, In Press

30. Worthington-Kirsch RL, Robert AC, Iussich G, “Anti-Emetic Prophylaxis for Uterine Artery Embolization for the Treatment of Fibroids”, In Preparation

Other Publications

1. Worthington-Kirsch, R.L. "Placement of Two Titanium Greenfield Filters in a Patient with Duplication of the Infrarenal Inferior Vena Cava: Case Report and Anatomical Considerations"; Technique Spotlight...A Close-up View of Interventional Medicine, Vol. VI, 1992, Boston Scientific Corporation

2. Worthington-Kirsch, R.L. “Procedure Manual: Angiography and Interventional Radiology: Mercy Catholic Medical Center” (In House Publication)

3. Worthington-Kirsch, R.L. “Interventionalists Offer Management Option for Uterine Fibroids”; Women’s Imaging Report Diagnostic Imaging 21(3):47-49, March 1999

4. Worthington-Kirsch, RL. “Radiologists Play Vital Role in Dialysis Graft Interventions”; Diagnostic Imaging 21(7):61-65, July 1999

5. Goodwin SC, Landow WJ, Matalon TAS, Mauro MA, Pomerantz P, Worthington-Kirsch RL. “Opportunity and Responsibility: SCVIR’s Role with Uterine Artery Embolization” (Editorial) JVIR 2000; 11:409-410

6. Hutchins FL and Worthington-Kirsch RL. “Embolotherapy for Myoma-Induced Menorrhagia”; Obstetric and Gynecologic Clinics of North America 2000; 2:397-405

7. Worthington-Kirsch RL. “Embolisation of the Uterine Artery”; Hospital Healthcare Europe 2000/2001: R-15-R-17

8. Machan L, Goodwin SC, Worthington-Kirsch RL, Spies JA. “Fibroid Embolization: Periprocedural Care”; Seminars in Interventional Radiology 2000; 17:247-254

9. Worthington-Kirsch RL. “Building a Practice in Gynecologic Embolotherapy”; Seminars in Interventional Radiology 2000; 17:263-270

10. Spies J, Niedzwiecki G, Goodwin S, Patel N, Andrews R, Worthington-Kirsch RL, Lippman J, Machan L, Sacks D, Sterling K, Lewis C. “Training Standards for Physicians Performing Uterine Artery Embolization for Leiomyomata: Consensus Statement Developed by the Task Force of Uterine Artery Embolization and the Standards Division of the Society of Cardiovascular & Interventional Radiology - August 2000”; J Vasc Interv Radiol 2001; 12:19-21

11. Worthington-Kirsch RL. “Uterine Artery Embolization: State-of-the-Art and New Developments”; Intervention 2000 4:35-38

12. Goodwin SC, Bonilla SM, Sacks D, Reed RA, Spies JB, Landow WJ, Worthington-Kirsch RL. “Reporting Standards for Uterine Artery Embolization for the Treatment of Uterine Leiomyomata”; J Vasc Interv Radiol 2001; 12:1011-1020

13. Worthington-Kirsch RL. “Embolotherapy: Future Developments and Challenges”; Private Hospital Healthcare Europe 2002: R35

14. Vedantham S, Sterling KM, Goodwin SC, Spies JB, Shlansky-Goldberg R, Worthington-Kirsch RL, Andrews RT, Hovsepian DM, Smith SJ, Chrisman HB. “Uterine Fibroid Embolization: Preprocedure Assessment”; Techniques in Vascular and Interventional Radiology 2002; 5:2-16

15. Worthington-Kirsch RL, Andrews RT, Siskin GP, Shlansky-Goldberg R, Lipman JC, Goodwin SC, Bonn J, Hovsepian DM. “Uterine Fibroid Embolization: Technical Aspects”; Techniques in Vascular and Interventional Radiology 2002; 5:17-34

16. Siskin GP, Bonn J, Worthington-Kirsch RL, Smith SJ, Shlansky-Goldberg R, Machan LS, Andrews RT, Goodwin SC, Hovsepian DM. “Uterine Fibroid Embolization: Pain Management”; Techniques in Vascular and Interventional Radiology 2002; 5:35-43

17. Lipman JC, Smith SJ, Spies JB, Siskin GP, Machan LS, Bonn J, Worthington-Kirsch RL, Goodwin SC, Hovsepian DM. “Uterine Fibroid Embolization: Follow-Up”; Techniques in Vascular and Interventional Radiology 2002; 5:44-55

18. Sterling KM, Vogelzang RL, Chrisman HB, Worthington-Kirsch RL, Machan LS, Goodwin SC, Andrews RT, Hovsepian DM, Smith SJ, Bonn J. “Uterine Fibroid Embolization: Management of Complications”; Techniques in Vascular and Interventional Radiology 2002; 5:56-66

19. Chrisman HB, Smith SJ, Sterling KM, Vogelzang RL, Bonn J, Andrews RT, Worthington-Kirsch RL, Goodwin SC, Lipman JC, Siskin GP, Hovsepian DM “Uterine Fibroid Embolization: Developing a Clinical Service”; Techniques in Vascular and Interventional Radiology 2002; 5:67-76

20. Worthington-Kirsch RL. “The Uterine Artery Embolization Procedure - A Follow-Up”; Today’s Harrisburg Woman, May 2002, Page 36

21. Worthington-Kirsch RL. “Health: Uterine Artery Embolization: An Effective Treatment for Fibroid Disease”; Today’s Woman, August 2002, Page 52

22. Worthington-Kirsch RL. "Uterine Artery Embolization - This therapeutic option for treating fibroid disease has steadily gained acceptance due to its advantages over surgical therapies"; Endovascular Today, September 2004; http://www.evtoday.com/PDFarticles/0904/et0904_women.pdf

23. Andrews RT, Spies JB, Sacks D, Worthington-Kirsch RL, Niedzwiecki GA, Marx MV, Hovsepian DM, Miller DL, Siskin GP, Raabe RD, Goodwin SC, Min RJ, Bonn J, Cardella JF, Patel NH. “Patient Care and Uterine Artery Embolization for Leiomyomata”, National Guideline Clearinghouse; J Vasc Interv Radiol 2004 Feb;15(2 Pt 1):115-20. PubMed http://www.guidelines.gov/summary/summary.aspx?view_id=1&doc_id=5394

24. Worthington-Kirsch RL,“Uterine Artery Embolization”, Endovascular Today 2004; 3:21-26

25. Worthington-Kirsch RL, “Uterine Artery Embolization for Fibroid Disease is Not Experimental”, Cardiovasc Interv Radiol 2005; 28:148-149
26. Worthington-Kirsch RL, “Injection Sclerotherapy”, Seminars in Interventional Radiology 2005; 22:209-217

27. Worthington-Kirsch RL, “Uterine Artery Embolization for Fibroid Disease”, Review and ADVANCE for Imaging In Press

Book Chapters

1. Worthington-Kirsch RL, Scott ME, Charnsanangavej C. “Pelvic Embolotherapy”, (Chapter), Taveras JM and Ferrucci JT, Eds, Radiology: Diagnosis, Imaging, Intervention 2000 Edition, Lippincott, Williams & Wilkins, Philadelphia, PA, USA, 2000 (also available on CD-ROM)

2. Worthington-Kirsch RL, Hughes LA. “Uterine Artery Embolization - Vascular Anatomic Considerations and Procedure Techniques”; Tulandi T (Editor) Uterine Fibroids: Embolization and Other Treatments Cambridge University Press, Cambridge, UK, 2003.

3. Worthington-Kirsch RL, Landow WJ. “The Future of Fibroid Embolotherapy: A Radiological Perspective”; Tulandi T (Editor), Uterine Fibroids: Embolization and Other Treatments, Cambridge University Press, Cambridge, UK, 2003

4. Hutchins, Francis L., Worthington-Kirsch RL. "The Fibroid Book 2nd Edition - A Guide to Treating the Most Common Cause of Hysterectomy", Chapter 6 - "A New Alternative: Uterine Artery Embolization".

5. Worthington-Kirsch RL, Uterine Artery Embolization for Fibroid Disease (Chapter), Van Sonnenberg E, McMullen W, Solbiati L, Eds, "Tumor Ablation: Principles and Practice", Springer Science + Business Media, New York, NY, USA, 2005

Other Media

1. Worthington-Kirsch, RL and Hutchins, FL “Embolotherapy of Uterine Myomata”; SCVIR Case Club, Case Reference No. CC-497-03. http://www.scvir.org (password protected), April 1997

2. Worthington-Kirsch, RL. “Aortobifemoral Graft Thrombolysis and Stenting”; SCVIR Case Club, Case Reference No. CC-797-08. http://www.scvir.org (password protected), July 1997

3. Worthington-Kirsch, RL. “Ovarian Vein Embolization”; SCVIR Case Club, Case Reference No. CC-797-10. http://www.scvir.org (password protected), July 1997

4. Worthington-Kirsch, RL. “Ovarian Vein Syndrome Diagnosed by CT Scan”; SCVIR Case Club, Case Reference No. CC-1298-03. http://www.scvir.org (password protected), December 1998

5. Worthington-Kirsch, RL. Online Chat - “Uterine Arterial Embolization: An Interventional Radiologist's Perspective”; WebMed.com/Sapient Health Network, April 13, 1999

6. Worthington-Kirsch, RL. “The Doctor’s In” (Live Call-In Radio Show), WWDB Radio (96.5 FM), Philadelphia. PA, October 3, 1999

7. Worthington-Kirsch, RL. “Gas Formation in the Uterus After Embolization of Fibroids”; SCVIR Case Club, Case Reference No. CC-1199-06. http://www.scvir.org (password protected), November 1999

8. Worthington-Kirsch, RL. “Severe Ovarian Vein Syndrome”; SCVIR Case Club, Case Reference No. CC-1199-07. http://www.scvir.org (password protected), November 1999

9. Worthington-Kirsch, RL. “Polymethylmethacrylate (PMMA) Glue Fixation of Pathologic Fracture of the Humerus”; SCVIR Case Club, Case Reference No. CC-1299-06. http://www.scvir.org (password protected), December 1999

10. Worthington-Kirsch, RL. “Embolization of Parasitized Ovarian Arteries in a Woman with Symptomatic Fibroids”; SCVIR Case Club, Case Reference No. CC-0100-07. http://www.scvir.org (password protected), January 2000

11. Spies J, Niedzwiecki G, Goodwin S, Patel N, Andrews R, Worthington-Kirsch RL, Lipman J, Machan L, Sacks D, Sterling K, Lewis C. “Training Standards for Physicians Performing Uterine Artery Embolization for Leiomyomata”; SCVIR Training Standard. http://www.scvir.org

12. Worthington-Kirsch, RL. “Family Talk” (Live Call-In TV Show), Topic - “Focus on Fibroids”, CN8, Union, NJ, April 12, 2001

13. Worthington-Kirsch, RL. “HealthCast” (TV Medical News Show), Topic – “ Uterine Artery Embolization”, CN8, Philadelphia, PA, April 27, 2003, May 11, 2003, May 25, 2003

Scientific Presentations

1. “Initial Experience with Uterine Artery Embolization for the Management of Symptomatic Uterine Fibroids”; Francis L. Hutchins, Jr, MD and R.L. Worthington-Kirsch, MD, International Congress of Gynecologic Endoscopy - Sponsored by The American Association of Gynecologic Laparoscopists (Seattle, WA), September 26, 1997

2. “Uterine Artery Embolization for the Management of Symptomatic Uterine Fibroids: Current Experience with 125 Patients with Follow-Up of up to One Year”; R.L. Worthington-Kirsch, MD, F.L. Hutchins, Jr., MD, and G.L. Popky, MD, FACR, Radiologic Society of North America (Chicago, IL), December 2, 1997

3. “Uterine Artery Embolization for Management of Symptomatic Fibroids: Mid-Term Results with 175 Patients and Follow-up to 18 Months”; R.L. Worthington-Kirsch, MD, F.L. Hutchins, Jr., MD, and G.L. Popky, MD American Roentgen Ray Society (San Francisco, CA), April 27, 1998

4. "Outcomes Analysis of Initial Experience with Uterine Artery Embolization (UAE) for Treatment of Myomas"; F.L. Hutchins, Jr, MD, R. L. Worthington-Kirsch, MD, The International Society for Gynecologic Endoscopy, Annual Regional Meeting "Uterine Leiomyoma", Amsterdam, The Netherlands, August 27-29, 1998

5. “Anatomic Variations in the Uterine Arteries: A Cause of Failure of Uterine Artery Embolization for the Management of Symptomatic Fibroids”; R.L. Worthington-Kirsch, MD, The 1st International Symposium on Embolization of Uterine Myomata, The Society for Minimally Invasive Therapy, 10th International Conference, London, UK, September 3-5, 1998

6. “Uterine Artery Embolization for the Management of Myomata in Patients without Complaints of Menorrhagia”; R.L. Worthington-Kirsch, MD, M.L. Delaney, DO, F.L. Hutchins, Jr, MD, The 1st International Symposium on Embolization of Uterine Myomata The Society for Minimally Invasive Therapy, 10th International Conference London, UK, September 3-5, 1998

7. “Experience with 200 Consecutive Cases of Uterine Artery Embolization for Management of Symptomatic Uterine Fibroids”; F.L. Hutchins, Jr, MD, R.L. Worthington-Kirsch, MD, International Congress of Gynecologic Endoscopy, 27th Annual Meeting of the American Association of Gynecologic Laparoscopists, Atlanta, GA, November 11, 1998

8. “Time Course of Pain after Uterine Artery Embolization for Fibroid Disease”; R.L. Worthington-Kirsch, MD and Koller NE, The 2nd International Symposium on Embolization of Uterine Myomata, The Society for Minimally Invasive Therapy, 11th International Conference, Boston, MA, September 16-18, 1999

9. “Amenorrhea after Uterine Artery Embolization”, Berkowitz RP, Hutchins FL, Worthington-Kirsch RL. Global Congress of Gynecologic Endoscopy 28th Annual Meeting of the American Association of Gynecologic Endoscopists Las Vegas, NV, November 8-11, 1999

10. “Evaluation of Pain after Uterine Artery Embolization”, Worthington-Kirsch RL. Biosphere Medical Investigators Meeting, San Diego, CA, March 28, 2000

11. “Initial US Experience with EmbospheresÔ for Embolization of Uterine Leiomyomata”; Spies JB, Benenati JF, Worthington-Kirsch RL. Uterine Artery Embolization (UAE) Conference Emerging Interventional Therapies Weekend Society of CardioVascular & Interventional Radiology, Washington, DC, October 13-14, 2000

12. “Comparison of Embosphere and PVA Embolization Agents in a Porcine Renal Model”, Levine A, Kim D, Termin P, Worthington-Kirsch RL. Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2001 Annual Meeting and Postgraduate Course, Gothenburg, Sweden, September 22-26, 2001

13. “Uterine Artery Embolization (UAE) Using Embospheres: Initial Results of a Phase II Comparative Study”, Spies JB, Cooper JM, Worthington-Kirsch RL, Lipman JC, Benenati JM, McLucas B. Society of Cardiovascular & Interventional Radiology 27th Annual Scientific Meeting, Baltimore, MD, USA, April 6-11, 2002

14. “Uterine Artery Embolization for Leiomyomata using Embospheres: Interim Results of a Phase II Comparative Study”; Worthington-Kirsch RL. New Trends in Embolotherapy Symposium sponsored by Terumo and Biosphere Medical during the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2002 Annual Meeting and Postgraduate Course, Luzerne, Switzerland, October 7, 2002

15. “Outcome from Uterine Embolization and Hysterectomy for Treatment of Leiomyomas: Results of a Multi-Center Comparative Study”; Spies JB, Cooper JA, Worthington-Kirsch RL, Lipman JC, Mills B, Benenati JF. Society of Interventional Radiology 28th Annual Scientific Meeting, Salt Lake City, UT, March 27 - April 1, 2003

16. The CIRREF FIBROID Registry Writing Committee CIRREF FIBROID “Registry Procedural Data - How Is UAE Performed?”, Worthington-Kirsch RL. Society of Interventional Radiology 28th Annual Scientific Meeting, Salt Lake City, UT, March 27 - April 1, 2003

17. The CIRREF FIBROID Registry Writing Committee CIRREF FIBROID ‘Registry Procedural Data - Procedural Data and Short-Term Outcomes CIRSE 2003’, Worthington-Kirsch RL. Antalya, Turkey, September 20-24, 2003

18. The CIRREF FIBROID Registry Writing Committee CIRREF FIBROID “Registry Procedural Data - Procedural Data and Short-Term Outcomes RSNA 2003”, Worthington-Kirsch RL. Chicago, IL, USA, November 30 - December 5, 2003

19. “Anti-Emetic Prophylaxis for Uterine Artery Embolization RSNA 2003”, Iussich G, Worthington-Kirsch RL, Roberts AC Chicago, IL, USA, November 30 - December 5, 2003

20. The Fibroid Registry for Outcomes Data (FIBROID) for Uterine Artery Embolization: Procedural Outcomes and Short Term (30 Day) Results, SIR 2005 New Orleans, LA, March 31 - April 5, 2005, Worthington-Kirsch RL, Spies JB, Myers E, Mulgund J, Mauro MA, Pron G, Peterson E, Goodwin SC

Research Projects

1. Uterine Artery Embolization for the Management of Fibroid Disease IRB - 1997 – 1; 1/97 - 8/97. Graduate Health Systems - City Avenue Hospital, R.L. Worthington-Kirsch

2. Uterine Artery Embolization for the Management of Fibroid Disease Ongoing Clinical Research, 9/96 – Present, Graduate Health Systems - City Avenue Hospital (9/96 - 8/97), Roxborough Memorial Hospital (9/97 - Present), R.L. Worthington-Kirsch

3. An Investigation of Steroids Use for Management of Pain Associated with Post Uterine Artery Embolization for Treatment of Symptomatic Leiomyomata Uteri (Fibroids), IRB Approved 11/98 - 3/99, Roxborough Memorial Hospital, Francis L. Hutchins, Jr., Robert L. Worthington-Kirsch, Nnaemeka M. Umerah

4. Comparison of Conscious Sedation and Limited Spinal Anesthesia in Management of Pain After Uterine Artery Embolization for Fibroid Disease, 7/99 - 8/99, Roxborough Memorial Hospital, R.L. Worthington-Kirsch, N.E. Koller

5. Use of EmbosphereÔ for Uterine Artery Embolization for the Management of Fibroid Disease (Phase I Trial), Sponsored by Biosphere Medical, IRB Approved 1/00 - 1/03, Roxborough Memorial Hospital, R.L. Worthington-Kirsch

6. Use of EmbosphereÔ for Uterine Artery Embolization for the Management of Fibroid Disease (Phase II Trial), Sponsored by Biosphere Medical, IRB Approved 10/00 – Present, Roxborough Memorial Hospital, R.L. Worthington-Kirsch

7. Clinical Investigation of the Contour Emboli PVA and FasTRACKER-325 Infusion Catheter for use in Uterine Artery Embolization for the Management of Uterine Fibroids, Sponsored by Boston Scientific/Medi-Tech, IRB Approved, 8/01 - Present Roxborough Memorial Hospital, R. L. Worthington-Kirsch

8. Clinical Investigation of the Contour-SE PVA and FasTRACKER-325 Infusion Catheter for use in Uterine Artery Embolization for the Management of Uterine Fibroids, Sponsored by Boston Scientific/Medi-Tech, IRB Approved 8/02 - Present Roxborough Memorial Hospital, R. L. Worthington-Kirsch

Peer Review

1. American Family Physician

2. Journal of Vascular & Interventional Radiology - Distinguished Reviewer Award 2002, 2003, 2004

3. American Journal of Obstetrics and Gynecology

4. CardioVascular & Interventional Radiology

5. Human Reproduction Journals

6. Medical Science Monitor

Consulting Positions

1. Boston Scientific - July 1998 - Present

2. Biosphere Medical - September 1999 - Present

3. BioCure - March 2002 - Present

4. Vascular Solutions - March 2004 - Present

5. BioCompatibles/Terumo - September 2004 - Present

Speaker Boards

1. Biosphere Medical
2. Boston Scientific
3. Terumo
4. VNUS

Invited Lectures

1. “Pelvic Ultrasound”, OB/GYN Grand Rounds, Philadelphia College of Osteopathic Medicine, June 1, 1995

2. “TIPSS”, Surgery Grand Rounds, Philadelphia College of Osteopathic Medicine, September 19, 1995

3. “Interventional Radiology In GastroIntestinal Disorders”, New Approaches to Common Gastrointestinal Disorders, Philadelphia College of Osteopathic Medicine CME Program, October 7, 1995

4. “Hereditary Hemmorrhagic Telangiectasia: Case Presentation and Clinical Management”, Medicine Grand Rounds, Philadelphia College of Osteopathic Medicine, April 10, 1996

5. “Interventional Radiology in the Evaluation and Management of the Jaundiced Patient”, GastroIntestinal Disorders In Office Practice, Philadelphia College of Osteopathic Medicine CME Program October 26, 1996

6. “Interventional Radiology: An Overview”, Radiology Course, PCOM 2nd Year Curriculum, Philadelphia College of Osteopathic Medicine, January 17, 1997

7. “Treatment Alternatives for Fibroid Management”, Ob/Gyn Grand Rounds, Allegheny University Hospitals, June 27, 1997

8. “Uterine Artery Embolization for the Management of Symptomatic Uterine Fibroids - The Philadelphia Experience”, R.L. Worthington-Kirsch, MD, Radiology Department Conference, Georgetowne University Medical Center, Washington, D.C. October 3, 1997

9. “Uterine Embolization and Other Interventions”, Robert L. Worthington-Kirsch, MD, Roxborough Memorial Hospital, Tuesday Afternoon Lecture Series (CME Series Sponsored Jointly by Roxborough Memorial Hospital and Allegheny University of the Health Sciences Office of Continuing Medical Education), Roxborough Memorial Hospital, Philadelphia, PA January 13, 1998

10. “Uterine Artery Embolization for the Management of Fibroids and Other Gynecologic Embolizations”, Robert L. Worthington-Kirsch, MD, New England Society for CardioVascular and Interventional Radiology, Natick, MA May12, 1998

11. “Uterine Artery Embolization for the Management of Fibroid Disease”, Robert L. Worthington-Kirsch, MD, The 7th Annual Interventional Radiology and Endovascular Therapy Seminar Midwest Institute for Interventional Therapy, Oak Brook, IL July 10–12, 1998

12. “Evaluation and Management of Ovarian Vein Syndrome”, Robert L. Worthington-Kirsch, MD, The 7th Annual Interventional Radiology and Endovascular Therapy Seminar Midwest Institute for Interventional Therapy, Oak Brook, IL July 10–12, 1998

13. "Uterine Artery Embolization for Fibroid Disease", Chicago Cardiovascular and Interventional Radiology Society Chicago, IL September 9, 1998

14. “Gynecologic Embolotherapy”, Ob/Gyn Grand Rounds Allegheny - Elkins Park Hospital, Elkins Park, PA October 14, 1998

15. “Gynecologic Embolotherapy”, Philadelphia Area ARNA (American Radiological Nurses Association) Abington, PA November 17, 1998

16. “Uterine Artery Embolization: Role in the Management of Uterine Leiomyoma”, Advanced Laparoscopic and Hysteroscopic Gynecologic Surgery - The Third Annual Frances C. Schaeffer, MD Memorial Symposium, Lehigh Valley Hospital Allentown, PA December 4, 1998

17. “Gynecologic Embolotherapy”, Ob/Gyn Grand Rounds, The Reading Hospital and Medical Center, Reading, PA February 24, 1999

18. “Alternative Treatments to Hysterectomy for Women with Uterine Fibroids”, Aurora Health Care/St. Luke’s Medical Center, Milwaukee, WI March 6, 1999

19. Workshop Series - “Gynecologic Interventions” Uterine Artery Embolization, Ovarian Vein Embolization , Society of CardioVascular & Interventional Radiology 24th Annual Meeting, Orlando, FL March 20-25, 1999 Received "Distinguished Faculty Award" from the SCVIR for this presentation

20. “Gynecologic Embolotherapy”, Ob/Gyn Resident Grand Rounds, Philadelphia College of Osteopathic Medicine, Philadelphia, PA April 22, 1999

21. “Gynecologic Embolotherapy”, Ob/Gyn Grand Rounds, Nesbitt Memorial Hospital, Wyoming Valley Health Care System, Kingston, PA June 30, 1999

22. “Anatomic Variants in UAE: Recognition and Management”, Worthington-Kirsch RL and Schadle SL The 2nd International Symposium on Embolization of Uterine Myomata, The Society for Minimally Invasive Therapy, 11th International Conference Boston, MA September 16-18, 1999

23. “Selective Uterine Artery Embolization as Primary Treatment for Symptomatic Leiomyomata Uteri: A Review of 305 Consecutive Cases”, Hutchins FL, Worthington-Kirsch RL and Berkowitz RP. The 2nd International Symposium on Embolization of Uterine Myomata, The Society for Minimally Invasive Therapy, 11th International Conference Boston, MA September 16-18, 1999

24. “Uterine Artery Embolization for Fibroid Disease: Experience in the Community Setting”, Interventional Radiology & Vascular Imaging ’99, Department of Radiology - Hospital of the University of Pennsylvania, Philadelphia, PA October 17-20 1999

25. “Gynecologic Embolotherapy”, International Pelvic Pain Society - Annual Meeting, Fort Lauderdale, FL October 20, 1999

26. “Anatomic Variants in UAE: Recognition and Management”, SCVIR Conference on Uterine Fibroid Embolization, McLean, VA October 22-23, 1999

27. “Gynecologic Embolotherapy”, Chippenham Medical Center/Johnson-Willis Hospital Angiography/ Interventional Radiology Series, Richmond Angiography/Interventional Radiology Society, Richmond, VA November 2, 1999

28. “Gynecologic Embolotherapy”, Ob/Gyn Grand Rounds, St. Agnes Hospital, Baltimore, MD November 10, 1999

29. “Gynecologic Embolotherapy”, Ob/Gyn Grand Rounds, Staten Island University Hospital, Staten Island, NY March 1, 2000

30. “Gynecologic Embolotherapy”, Ob/Gyn Grand Rounds, Mercy Suburban Hospital, Norristown, PA March 6, 2000

31. “Gynecologic Embolotherapy”, Monthly Medical Education Meeting, Planned Parenthood Association of Bucks County, Doylestown, PA March 9, 2000

32. “Anatomic Variants in UAE: Recognition and Management”, SCVIR Symposium on Gynecologic Interventions, San Diego, CA March 25, 2000

33. “Anatomic Variants in UAE: Recognition and Management”, AVIR (Association of Vascular and Interventional Radiographers) Annual Scientific Meeting, San Diego, CA March 26, 2000

34. “Evaluation and Management of Ovarian Vein Syndrome”, AVIR (Association of Vascular and Interventional Radiographers) Annual Scientific Meeting, San Diego, CA March 26, 2000

35. Workshop Series - “Gynecologic Interventions” Uterine Artery Embolization, Ovarian Vein Embolization Society of CardioVascular & Interventional Radiology 25th Annual Meeting, San Diego, CA March 26-30, 2000

36. “Gynecologic Embolotherapy”, Patient Care Management Meeting First Priority Health - Blue Cross of Northeastern Pennsylvania, Wilkes-Barre, PA May 18, 2000

37. “Gynecologic Embolotherapy”, Ob/Gyn Grand Rounds, Philadelphia College of Osteopathic Medicine, Philadelphia, PA September 7, 2000

38. “UFE Techniques and Vascular Anatomic Considerations”, “UFE: The Philadelphia Experience” 1st Canadian Symposium on Uterine Fibroid Embolization, Toronto, Ontario, Canada September 23, 2000. Dr. Worthington-Kirsch was the Keynote Speaker for this meeting.

39. “Introduction and Welcome”, (Overview of History of UAE) Uterine Artery Embolization (UAE) Conference Emerging Interventional Therapies Weekend, Society of CardioVascular & Interventional Radiology, Washington, DC October 13-14, 2000

40. “Advanced UAE: Anatomic Variants and Problems”, Uterine Artery Embolization (UAE) Conference Emerging Interventional Therapies Weekend, Society of CardioVascular & Interventional Radiology, Washington, DC October 13-14, 2000

41. “Gynecologic Embolotherapy”, Ob/Gyn Grand Rounds, Chestnut Hill Hospital, Philadelphia, PA October 17, 2000

42. Hutchins FL, Miller CE, Worthington-Kirsch RL, Tulandi T. “The Great Debate: UAE vs. Myomectomy for the Treatment of Large Fibroids”, Global Congress of Gynecologic Endoscopy 29th Annual Meeting of the American Association of Gynecologic Laparoscopists, Orlando, FL November 19, 2000

43. “Gynecologic Embolotherapy”, Ob/Gyn Grand Rounds, Albert Einstein Medical Center, Philadelphia, PA December 6 , 2000

44. “Anatomy Relevant to UAE”, Categorical Course in Women’s Health, Society of CardioVascular & Interventional Radiology 26th Annual Meeting, San Antonio, TX March 6, 2001

45. Workshop Series - “Gynecologic Interventions” Uterine Artery Embolization, Ovarian Vein Embolization Society of CardioVascular & Interventional Radiology 26th Annual Meeting San Antonio, TX March 3-8, 2001

46. “Gynecologic Embolotherapy” Plenary Session Lecture American College of Osteopathic Obstetricians and Gynecologists 68th Annual Meeting Orlando, FL March 25, 2001

47. “Gynecologic Embolotherapy” Ob/Gyn Grand Rounds MCP Hahnemann University Hospital Philadelphia, PA April 17, 2001

48. “Fibroid Embolotherapy” San Diego Angio Club University of California at San Diego San Diego, CA April 18, 2001

49. “Fibroid Embolotherapy” Inland Empire Angio Club Loma Linda University Loma Linda, CA April 19, 2001

50. “Uterine Artery Embolization” New Trends in Myoma Management Including Uterine Fibroid Embolization St. Thomas’ Hospital London, England May 31, 2001

51. Worthington-Kirsch RL, Stubbs J “UAE is Experimental and Dangerous” (debate) New Trends in Myoma Management Including Uterine Fibroid Embolization St. Thomas’ Hospital London, England May 31, 2001

52. “Technical Problems and Failures in UAE” New Trends in Myoma Management Including Uterine Fibroid Embolization St. Thomas’ Hospital London, England June 1, 2001

53. “Clinical Experience with EmbosphereÔ Microspheres and PVA for UAE Technique Modifications and Embolizant Choice” Embosphere Microspheres, A Difference forManagement of the UFE Procedure Symposium sponsored by Biosphere Medical as a companion to: New Trends in Myoma Management Including Uterine Fibroid Embolization London, England June 1, 2001

54. “Uterine Artery Embolization for the Treatment of Uterine Fibroids” Keynote Speaker Embolização Uterina para Tratamento do Mioma Sintomático (Uterine Embolization for Treatment of Symptomatic Fibroids) Sponsored by: Centro de Estudos do Hospital Santa Catarina SOBRICE (Interventional Radiology Society of Brazil) CBR (Brazilian College of Radiology) FEBRASCO (Brazilian Federation of Gynecology and Obstetrics) São Paolo, Brazil August 2, 2001

55. “TIPSS”, Medical Student Lecture, Hospital Héliopolis, São Paolo, Brazil, August 3, 2001

56. “Uterine Artery Embolization for the Management of Symptomatic Fibroids”, Ob/Gyn Grand Rounds, Robert Wood Johnson Hospital System - Hamilton Division, Hamilton, NJ, August 14, 2001

57. Uterine Fibroid Embolization Workshop, Cardiovascular and Interventional Radiological Society of Europe (CIRSE), 2001 Annual Meeting and Postgraduate Course, Gothenburg, Sweden, September 23, 2001

58. “SCVIR/CIRREF FIBROID Registry”, Satellite Symposium entitled “Practice Building in UFE”, Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2001 Annual Meeting and Postgraduate Course, Gothenburg, Sweden, September 23, 2001

59. Panel Discussion Participant, Satellite Symposium entitled “New Trends in Embolotherapy”, Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2001 Annual Meeting and Postgraduate Course, Gothenburg, Sweden, September 24, 2001

60. “Gynecologic Embolotherapy”, Ob/Gyn Grand Rounds, Pennsylvania Hospital (Univ. of PA Health Systems), Philadelphia, PA, October 10, 2001

61. “Gynecologic Embolotherapy”, Ob/Gyn Grand Rounds, Main Line Health Systems (Thomas Jefferson University Hospitals), Bryn Mawr, PA, October 17, 2001

62. “Fibroid Embolotherapy: Technique and Vascular Anatomic Considerations”, 6th McGill International Symposium on Reproductive Endocrinology, Infertility, and Uterine Fibroid Embolization, Montreal, Canada, October 19, 2001

63. “UAE: The Philadelphia Experience - Radiologic Perspective”, 6th McGill International Symposium on Reproductive Endocrinology, Infertility, and Uterine Fibroid Embolization, Montreal, Canada, October 19, 2001

64. “Uterine Artery Embolization for Fibroid Disease”, Interventional Radiology/Ob-Gyn Grand Rounds, Northern Kentucky Radiology Associates, Covington, KY, February 20, 2002

65. “Uterine Artery Embolization for Fibroid Disease”, Interventional Radiology Grand Rounds, Johns Hopkins University Hospital, Baltimore, MD, March 19, 2002

66. Workshop Series - “Gynecologic Interventions”, Uterine Artery Embolization, Ovarian Vein Embolization, Society of CardioVascular & Interventional Radiology 27th Annual Meeting, Baltimore, MD, April 6-11, 2002

67. Workshop Series - “FIBROID Registry”, Uterine Artery Embolization, Ovarian Vein Embolization, Society of CardioVascular & Interventional Radiology 27th Annual Meeting, Baltimore, MD, April 6-11, 2002

68. “UAE: Advanced Technical Considerations”, Society of CardioVascular & Interventional Radiology 27th Annual Meeting, Women’s Health Categorical Course, Baltimore, MD, April 9, 2002

69. “UAE: New Challenges”, Society of CardioVascular & Interventional Radiology 27th Annual Meeting, “Lessons Learned” Lecture Series, Baltimore, MD, April 10, 2002

70. “Uterine Fibroid Embolization”, Society of Interventional Radiology CME Course, “Embolotherapy: Materials, Techniques, and Clinical Applications”, Pasadena, CA, June 21, 2002

71. “Uterine Artery Embolization for Fibroid Disease”, Central PA Chapter of the American Association of Clinical Coders, Harrisburg, PA, November 14, 2002

72. “UAE in the USA Today” - Panel Discussion entitled “The Role of the Gynecologist in Uterine Artery Occlusion for Fibroids”, Global Congress of Gynecologic Endoscopy American Association of Gynecologic Laparoscopists, 31st Annual Meeting, Miami, FL, November 21, 2002

73. “Minimally Invasive Therapy for Superficial Venous Insufficiency”, Sidney H. Orr CME Lecture Series, Roxborough Memorial Hospital, Philadelphia, PA, November 26, 2002

74. “Vascular Anatomy, Technical Considerations, and Embolization Agents”, Plenary Session - Uterine Fibroid Embolization, Society of Interventional Radiology 28th Annual Scientific Meeting, Salt Lake City, UT, March 27-April 1, 2003

75. “UAE - Frequently Asked Questions and Lessons Learned”, Symposium Moderator Uterine Fibroid Embolization: Educating Physicians, Patients and Payers on the Benefits of UFE Symposium sponsored by Biosphere Medical, parallel to Society of Interventional Radiology 28th Annual Scientific Meeting, Salt Lake City, UT, March 29, 2003

76. Workshop Series - Gynecologic Interventions, Society of Interventional Radiology 28th Annual Scientific Meeting, Salt Lake City, UT March 29, 2003

77. “Uterine Artery Embolization - One Practice’s Experience”, Program S8 - Uterine Fibroids Program Moderator, International Society for Gynecologic Endoscopy 12th Annual Congress, Cancun, Mexico, April 3-5, 2003

78. “Controversies in IR Debate: The Case for UFE is Settled”, CIRSE 2003, Antalya, Turkey, September 20-24, 2003.

79. “Diagnosis and Management of Superficial Venous Insufficiency”, Geriatrics Core Curriculum Lecture Series, Hahnemann University/MCP Department of Medicine Philadelphia, PA, February 11, 2004

80. “Lessons Learned: Uterine Artery Embolization” – Panel Society of Interventional Radiology 29th Annual Scientific Meeting, Phoenix, AZ, March 27, 2004

81. Workshop Series - Gynecologic Interventions - Presentation on Practice Development Society of Interventional Radiology 29th Annual Scientific Meeting, Phoenix AZ, March 29, 2003

82. Workshop Series - Practice Development: How to Build an IR Practice Today, in the Real World: Case Study Approach, Society of Interventional Radiology 29th Annual Scientific Meeting, Phoenix AZ, March 29, 2003

83. Simposio Internacional Sobre Embolizacao de Miomas Uterinos (International Symposium on Embolization of Uterine Myomas) Keynote Speaker, Nucleo Central do Colgio Brasileiro de Cirurgioes - Secao de Ginecologia (Gynecology Section - Brazilian College of Surgeons), Rio de Janeiro, Brazil, April 17, 2004

84. Avances de Terapeutica Endovascular en Ginecologia (Advances in Endovascular Therapy in Gynecology) Keynote Speaker & Live Case, Sociedad Argentine de Radiologia (Argentine Society of Radiology), Hospital Italiano de Buenos Aires Buenos Aires, Argentina, April 19, 2004

85. Avances de Terapeutica Endovascular en Ginecologia - Embolizacion de Miomas Uterinos (Advances in Endovascular Therapy in Gynecology - Embolization of Uterine Myomas) Keynote Speaker & Live Cases, (First cases of UAE for fibroids in Uruguay) Departamento of Ginecologia y Departamento de Imagenologia del Hospital Central de las Fuerzas Armadas, Montevideo, Uruguay, April 20, 2004

86. Uterine Artery Embolization for Fibroid Disease, Ob/Gyn Grand Rounds, Hahnemann University Hospital, Philadelphia, PA, April 27, 2004

87. Fibroid Embolization: When to Refer Your Patient. Symposium sponsored by Biosphere Medical, American College of Obstetricians and Gynecologists (ACOG) 52nd Annual Meeting, Philadelphia, PA May 4, 2004
88. Advanced Ultrasound Techniques: Venous Insufficiency Diagnosis and Treatment Faculty/Keynote Speaker, CME Course sponsored by VNUS Medical Technologies, Inc., Teaneck, NJ, June 11, 2004

89. Treatment of Varicose Veins (CS3.17.6), 23rd International Congress of Radiology of the International Society of Radiology, Montreal, Quebec, CANADA, June 25-29, 2004

90. Current Status of Uterine Fibroid Embolization (CS3.30.3), 23rd International Congress of Radiology of the International Society of Radiology, Montreal, Quebec, CANADA, June 25-29, 2004

91. Anatomic and Technical Considerations for UAE, Uterine Fibroid Embolization: A Series of Tutorials for Practicing Interventional Radiologists, Society of Interventional Radiology, Seattle, WA, USA, October 8-9, 2004

92. UAE - Review of Outcomes Data Uterine Fibroid Embolization: A Series of Tutorials for Practicing Interventional Radiologists, Society of Interventional Radiology, Seattle, WA, USA, October 8-9, 2004

93. UAE Masters’ Class, Sponsored by Biocompatibles/Terumo Medical, Los Angeles, CA, December 2, 2004

94. Percutaneous Vertebroplasty, Roxborough Memorial Hospital Grand Rounds, Philadelphia, PA, December 14, 2004

95. UAE Overview - A Physician’s Perspective, Terumo Interventional Systems 2005 Annual Sales & Marketing Meeting, Marco Island, FL, February 9, 2005

96. Uterine Artery Embolization for Fibroid Disease, Chestnut Hill Hospital Ob/Gyn Grand Rounds, Philadelphia, PA, February 15, 2005

97. Evaluation and Treatment of Superficial Venous Insufficiency, Delaware County Memorial Hospital Grand Rounds, Drexel Hill, PA, March 5, 2005

98. Uterine Artery Embolization for Fibroid Disease, American Roentgen Ray Society 105th Annual Meeting, New Orleans, LA, May 16, 2005

99. Permanent Non-Surgical Birth Control for Women - Fluoro-ESSURE, American Roentgen Ray Society 105th Annual Meeting, New Orleans, LA, May 16, 2005

100. Evaluation and Treatment of Superficial Venous Insufficiency, Radiology Grand Rounds Rhode Island Hospital/Brown University School of Medicine, Providence, RI, July 22, 2005

101. How to Run an IR Consultation Office (Why Go Solo in IR?), Cardiovascular and Interventional Radiology Society of Europe (CIRSE), Nice, France, September 10-15, 2005

102. Clinical Examination and Venous Duplex of Patients with Varicose Veins, Cardiovascular and Interventional Radiology Society of Europe (CIRSE), Nice, France, September 10-15, 2005

103. How I Do Endovenous Ablation, Cardiovascular and Interventional Radiology Society of Europe (CIRSE), Nice, France, September 10-15, 2005

104. Minimally Invasive Treatment of Superficial Venous Insufficiency - Treatment Outcomes, Cardiovascular and Interventional Radiology Society of Europe (CIRSE), Nice, France, September 10-15, 2005

revised 04/2010